TORONTO, May 18, 2011 /CNW/ - The Bochner Eye Institute is the first
centre in Canada to offer the KXL System for Accelerated Cross-linking
- a non-invasive, incision‐less procedure for treating keratoconus.
"Surgeons at the Bochner Eye Institute are always at the forefront of
new technology and are among the most experienced at corneal
cross-linking in the world," said David Muller, PhD, CEO of Avedro.
Keratoconus is a degenerative disorder, which causes the cornea to thin
and bulge from its natural state to a conical shape resulting in
distortion of vision, and is a leading cause of corneal transplants.
The KXL System provides therapeutic treatment for keratoconus in just a
few minutes, as opposed to the previous treatments that took over an
hour to complete.
"The KXL procedure is a breakthrough in corneal cross-linking that has
proven safe and effective in stopping the progression of keratoconus,"
says Raymond Stein, MD, FRCSC, Medical Director of Bochner Eye
Corneal cross-linking combines the application of riboflavin with
ultraviolet‐A (UVA) light. Together, these increase corneal strength
and stability by inducing new cross-links between or within collagen
fibers. In multiple international clinical trials, cross-linking has
been shown to halt the progression of keratoconus and to enhance the
biomechanical stability of the cornea.
"Were happy to offer our keratoconic patients a safe, non-surgical
alternative to corneal transplants that quickly and gently reshapes the
cornea," says Albert Cheskes, MD, FRCSC, Medical Director of Bochner
Key benefits of the KXL System include:
Speed: 3 minutes, 30 mW/cm"
Performance: Internal power calibration, increased depth of field, computer
Predictability: Top hat homogeneous beam profile
About Avedro, Inc.
Avedro, a privately held ophthalmic device and drug company based in
Waltham, MA, developed the KXL System for performing Accelerated
Cross-linking. For more information on Avedro, visit www.avedro.com.
About The Bochner Eye Institute
The Bochner Eye Institute was established in 1929 and is a full-service
ophthalmic surgical facility. Surgical procedures include cataract
surgery, LASIK, PRK, PTK, corneal cross-linking, intracorneal rings,
phakic implants, and therapeutic YAG and SLT laser treatments. A
diagnostic centre provides testing with elevation and curvature
topography, optical coherence topography, high-resolution fundus and
anterior segment photography, specular microscopy, and biomechanical
properties of the cornea. The surgeons at the Bochner Eye Institute all
have academic appointments to the University of Toronto and have
authored over 35 books.
SOURCE Bochner Eye Institute
For further information:
Director of Marketing and Education
416-960-2020 ext 258